TEVA PHARMACEUTICAL INDUSTRIES LTD reports

Company location: Tel Aviv
Fiscal year end: 31 December

TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,493 SEC EDGAR filings since 02 Feb 1996

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
40-F
6-K

SEC filing history

Showing 426-450 of 1,000 matching filings.

Per page

25

Current page

18

8-K File 001-16174

8-K

Filing date: 23 Jun 2022
Reporting date: 23 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Jun 2022
Reporting date: 14 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SD File 001-16174

SD

Filing date: 25 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 19 May 2022
Reporting date: 17 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-16174

10-Q

Filing date: 03 May 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-16174

TEVA PHARMACEUTICAL INDUSTRIES LIMITED 8-K

Filing date: 03 May 2022
Reporting date: 03 May 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-16174

DEFA14A

Filing date: 13 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-16174

DEF 14A

Filing date: 13 Apr 2022
Reporting date: 23 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-16174

PRE 14A

Filing date: 15 Mar 2022
Reporting date: 23 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 08 Mar 2022
Reporting date: 04 Mar 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .